Comprehensive Mutation Analysis for Congenital Muscular Dystrophy: A Clinical PCR-Based Enrichment and Next-Generation Sequencing Panel

The congenital muscular dystrophies (CMDs) comprise a heterogeneous group of heritable muscle disorders with often difficult to interpret muscle pathology, making them challenging to diagnose. Serial Sanger sequencing of suspected CMD genes, while the current molecular diagnostic method of choice, can be slow and expensive. A comprehensive panel test for simultaneous screening of mutations in all known CMD-associated genes would be a more effective diagnostic strategy. Thus, the CMDs are a model disorder group for development and validation of next-generation sequencing (NGS) strategies for diagnostic and clinical care applications. Using a highly multiplexed PCR-based target enrichment method (RainDance) in conjunction with NGS, we performed mutation detection in all CMD genes of 26 samples and compared the results with Sanger sequencing. The RainDance NGS panel showed great consistency in coverage depth, on-target efficiency, versatility of mutation detection, and genotype concordance with Sanger sequencing, demonstrating the test's appropriateness for clinical use. Compared to single tests, a higher diagnostic yield was observed by panel implementation. The panel's limitation is the amplification failure of select gene-specific exons which require Sanger sequencing for test completion. Successful validation and application of the CMD NGS panel to improve the diagnostic yield in a clinical laboratory was shown.

[1]  Jay Shendure,et al.  Multiplex amplification of large sets of human exons , 2007, Nature Methods.

[2]  E. Mercuri,et al.  Relative frequency of congenital muscular dystrophy subtypes: Analysis of the UK diagnostic service 2001–2008 , 2012, Neuromuscular Disorders.

[3]  P. Shannon,et al.  Exome sequencing identifies the cause of a Mendelian disorder , 2009, Nature Genetics.

[4]  Emily H Turner,et al.  Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes , 2009, Nature.

[5]  U. Reed.  Congenital muscular dystrophy. Part II: a review of pathogenesis and therapeutic perspectives. , 2009, Arquivos de neuro-psiquiatria.

[6]  J. Mendell,et al.  The Congenital Muscular Dystrophies: Recent Advances and Molecular Insights , 2006, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[7]  M. Metzker.  Sequencing technologies — the next generation , 2010, Nature Reviews Genetics.

[8]  Christian Gilissen,et al.  Massively parallel sequencing of ataxia genes after array‐based enrichment , 2010, Human mutation.

[9]  R. Cohn,et al.  Congenital muscular dystrophies: new aspects of an expanding group of disorders. , 2007, Biochimica et biophysica acta.

[10]  David T. Okou,et al.  Microarray-based genomic selection for high-throughput resequencing , 2007, Nature Methods.

[11]  Fabio Macciardi,et al.  Targeted next-generation sequencing appoints c16orf57 as clericuzio-type poikiloderma with neutropenia gene. , 2010, American journal of human genetics.

[12]  G. Weinstock,et al.  Direct selection of human genomic loci by microarray hybridization , 2007, Nature Methods.

[13]  G. Weinstock,et al.  Targeted high-throughput DNA sequencing for gene discovery in retinitis pigmentosa. , 2009, Advances in experimental medicine and biology.

[14]  Z. Xuan,et al.  Genome-wide in situ exon capture for selective resequencing , 2007, Nature Genetics.

[15]  K. Frazer,et al.  Microdroplet-based PCR amplification for large scale targeted sequencing , 2009, Nature Biotechnology.

[16]  C. Bönnemann,et al.  Congenital muscular dystrophies and the extracellular matrix. , 2006, Seminars in pediatric neurology.

[17]  Hao Hu,et al.  Mutation screening in 86 known X-linked mental retardation genes by droplet-based multiplex PCR and massive parallel sequencing , 2009, The HUGO Journal.

[18]  I. Tikhonova,et al.  Genetic diagnosis by whole exome capture and massively parallel DNA sequencing , 2009, Proceedings of the National Academy of Sciences.

[19]  Mohsin Shahzad,et al.  Targeted capture and next-generation sequencing identifies C9orf75, encoding taperin, as the mutated gene in nonsyndromic deafness DFNB79. , 2010, American journal of human genetics.

[20]  W. Grody,et al.  Keeping up with the next generation: massively parallel sequencing in clinical diagnostics. , 2008, The Journal of molecular diagnostics : JMD.

[21]  A. Sharp,et al.  Detection of Genomic Variation by Selection of a 9 Mb DNA Region and High Throughput Sequencing , 2009, PloS one.

[22]  J. Maguire,et al.  Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing , 2009, Nature Biotechnology.

[23]  Emily H Turner,et al.  Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome , 2010, Nature Genetics.

[24]  K. Voelkerding,et al.  Next-generation sequencing: from basic research to diagnostics. , 2009, Clinical chemistry.

[25]  E. Kirkness.  Targeted sequencing with microfluidics , 2009, Nature Biotechnology.

[26]  Shashikant Kulkarni,et al.  Assuring the quality of next-generation sequencing in clinical laboratory practice , 2012, Nature Biotechnology.

[27]  P. D. Rijk,et al.  Simultaneous mutation and copy number variation (CNV) detection by multiplex PCR–based GS‐FLX sequencing , 2009, Human mutation.

[28]  Christian Gilissen,et al.  Exome sequencing identifies WDR35 variants involved in Sensenbrenner syndrome. , 2010, American journal of human genetics.

[29]  F. Muntoni,et al.  The congenital muscular dystrophies in 2004: a century of exciting progress , 2004, Neuromuscular Disorders.

[30]  Zhenyu Xuan,et al.  Hybrid selection of discrete genomic intervals on custom-designed microarrays for massively parallel sequencing , 2009, Nature Protocols.

[31]  Jay Shendure,et al.  Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia , 2010, Human molecular genetics.

[32]  M. Hegde,et al.  Assessment of target enrichment platforms using massively parallel sequencing for the mutation detection for congenital muscular dystrophy. , 2012, The Journal of molecular diagnostics : JMD.

[33]  U. Reed.  Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects. , 2009, Arquivos de neuro-psiquiatria.